aceatherapeutics
ACEA Therapeutics (aceatherapeutics.com) is a clinical-stage biopharmaceutical company developing innovative small-molecule and antibody-drug-conjugate treatments across oncology, autoimmune, and antiviral therapeutic areas, with product candidates including Olgotrelvir, Abivertinib, AC0058, STI-6129, and AC0939. Surfaced as a portfolio company of Qiming Venture Partners and added to the API Evangelist network. As a pharmaceutical company oriented toward patients, physicians, and investors, ACEA Therapeutics publishes no public developer API, documentation, SDK, or technical integration surface at this time; this profile captures its verifiable web/domain footprint only.
aceatherapeutics is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Pharmaceuticals, Healthcare, and Oncology.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API